US President-elect Donald Trump has appointed Dr. Jay Bhattacharya, a prominent critic of Covid-19 lockdowns and a Stanford University-trained physician and economist, to head the National Institutes of Health (NIH). The NIH, the world’s largest government-funded biomedical research organisation, will now be led by a figure renowned for challenging the conventional public health response to the pandemic.
Trump announced Bhattacharya’s appointment in a statement on Tuesday, describing the decision as part of his efforts to “restore the NIH to a gold standard of medical research.” Trump also emphasised that Bhattacharya would focus on addressing some of America’s most pressing health challenges, including chronic illnesses, and would spearhead reforms to modernise the country’s public health institutions.
In a statement on X (formerly Twitter), Bhattacharya expressed his gratitude and vision for the role. “We will reform American scientific institutions so that they are worthy of trust again and will deploy the fruits of excellent science to make America healthy again!” he wrote.
Bhattacharya’s Rise to Prominence
Dr. Bhattacharya became widely known during the Covid-19 pandemic for co-authoring the controversial Great Barrington Declaration. Released in October 2020, the declaration advocated for a strategy of “focused protection” for vulnerable populations while allowing others to resume normal life. It sharply criticised lockdowns and other measures taken to curb the spread of the virus, arguing that these actions caused unnecessary harm to public health and the economy.
The declaration drew both intense criticism and support. Dr. Francis Collins, the then-director of the NIH, labelled it “dangerous” and described its authors as “fringe experts.” However, others within the medical and scientific communities praised it as a reasonable alternative approach to managing the pandemic.
Bhattacharya has also been a vocal critic of Dr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases (NIAID), questioning the efficacy and long-term impact of public health measures implemented throughout the pandemic. His stance on the issue of Covid-19 has made him a polarising figure in the broader public health debate.
Trump’s Vision for Public Health Reform
Bhattacharya’s appointment aligns with President-elect Trump’s broader strategy to overhaul the US public health system. In addition to Bhattacharya’s nomination for the NIH, Trump has made several other high-profile health-related appointments that signal a shift away from traditional public health approaches.
Among the most notable is the selection of Robert Kennedy Jr., a vaccine sceptic and former rival, to head the Department of Health and Human Services (HHS). Kennedy’s appointment, alongside Bhattacharya’s, underscores Trump’s focus on restoring trust in the country’s public health agencies, which has eroded significantly during the pandemic.
In a statement, Trump indicated that his administration would prioritise finding solutions to the nation’s biggest health challenges. “We will examine the underlying causes of, and solutions to, America’s biggest health challenges,” Trump said, referencing a need for innovative approaches to improve public health and wellness.
More Read
Trump’s Controversial Team
Trump’s health leadership team features several figures who have questioned or opposed mainstream public health policies. Alongside Bhattacharya’s nomination, Trump’s choices include:
- Marty Makary, a surgeon from Johns Hopkins University who opposed Covid-19 vaccine mandates, named as the new head of the Food and Drug Administration (FDA).
- Dave Weldon, a physician and former Republican congressman who is sceptical of vaccine safety, selected to lead the Centers for Disease Control and Prevention (CDC).
- Dr. Mehmet Oz, a television personality and former candidate for US Senate, nominated to oversee the Centers for Medicare and Medicaid Services (CMS).
- Jim O’Neill, a former federal health official and ally of conservative donor Peter Thiel, who will become deputy secretary of the Health Department.
These appointments, which are subject to Senate confirmation, have drawn criticism from many corners. Critics argue that the selection of figures with controversial views on vaccines, lockdowns, and public health, as well as the choice of individuals with no formal experience in public health administration, could undermine efforts to rebuild the US health system post-pandemic.
In particular, Trump’s nomination of Dr. Janette Nesheiwat as surgeon general has caused division within his conservative base. Nesheiwat’s prior support for masking schoolchildren and her opposition to abortion restrictions has led to mixed reactions, with some conservatives questioning her alignment with their values.
Looking Ahead
With these appointments, Trump’s health reform agenda is becoming clearer. While his selection of figures who question mainstream health policies is intended to reshape the public health landscape, it remains to be seen how the new leadership will navigate the complexities of managing America’s health system in the wake of the pandemic. Critics are likely to continue scrutinising these appointments, while supporters hope they will usher in a new era of public health reform and scientific integrity.
